Reampla

Reampla uses and dosage

Reampla (Palbociclib), generic Ibrance is a prescription medicine used to treat hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative advanced breast cancer in women who have experienced menopause. Reampla manufactured by Pfizer Pharma Ltd. in Germany. Palbociclib has to take orally once a day with food for 21 consecutive days followed by 7 days off treatment to comprise a complete cycle of 28 days.

Reampla side effects

The most common adverse reaction of Palbociclib are: Nausea, vomiting, loss of appetite, diarrhea, tiredness, weakness, hair loss, mouth sores, or numbness/tingling of arms/legs.

Originator brand

Ibrance by Pfizer

Made by

Pfizer Inc

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.